These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10549728)

  • 1. Optimizing anticoagulant therapy in the management of pulmonary embolism.
    Goldhaber SZ
    Semin Thromb Hemost; 1999; 25 Suppl 3():129-33. PubMed ID: 10549728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The approach to massive pulmonary embolism.
    Goldhaber SZ
    Semin Respir Crit Care Med; 2000; 21(6):555-61. PubMed ID: 16088764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of patients with pulmonary embolism.
    Wells PS; Büller HR
    Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and management of pulmonary embolism.
    Abunasser J; Tejada JP; Foley RJ
    Conn Med; 2012 Jan; 76(1):5-14. PubMed ID: 22372172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customizing our approach in deep vein thrombosis and pulmonary embolism treatment: overview of our clinical experience.
    Turpie AG
    Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S107-15. PubMed ID: 10493239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in the treatment of venous thromboembolism.
    Garcia DA; Spyropoulos AC
    Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of life-threatening pulmonary embolism.
    Marshall PS; Mathews KS; Siegel MD
    J Intensive Care Med; 2011; 26(5):275-94. PubMed ID: 21606060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism.
    Olin JW
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S68-75. PubMed ID: 12556745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Cardiol Clin; 2008 May; 26(2):299-309, viii. PubMed ID: 18407002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies.
    Deitcher SR
    Semin Thromb Hemost; 2003 Jun; 29(3):247-58. PubMed ID: 12888929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful thrombolytic therapy for massive pulmonary embolism.
    Onuigbo M; Cuffy-Hallam M; Mangano A; Schwartz M; Alikhan M
    South Med J; 2000 Mar; 93(3):327-9. PubMed ID: 10728526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?
    Douma RA; Kamphuisen PW
    Semin Thromb Hemost; 2007 Nov; 33(8):821-8. PubMed ID: 18175288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.